Artwork

Content provided by GW Office for Clinical Practice Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GW Office for Clinical Practice Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Clinical Immunology: Developing a Vaccine for Hookworm

11:10
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on November 17, 2018 01:43 (6y ago). Last successful fetch was on September 10, 2018 12:25 (6y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 158658753 series 57058
Content provided by GW Office for Clinical Practice Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GW Office for Clinical Practice Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr. David Diemert is an innovative research focused on developing an effective hookworm vaccine and characterizing hookworm biology. An Associate Professor of The Department of Microbiology, Immunology, and Tropical Medicine (MITM), Dr. Diemert co-hosts the clinical immunology laboratory and clinical trials unit of the Sabin Vaccine Institute Product Development Partnership (Sabin PDP), an Albert B. Sabin Vaccine Institute-funded partnership to develop new vaccines for neglected tropical diseases. In collaboration, both labs are currently running five phase 1 clinical trials for a hookworm vaccine: Two of these trials are carried out at the Children’s National Medical Center and the GW Medical Faculty Associates in Washington D.C., two in collaboration with the Oswaldo Cruz Foundation (FIOCRUZ) in Belo Horizonte and Americaninhas (Minas Gerais) in Brazil and one in Lambaréné in Gabon.

  continue reading

42 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on November 17, 2018 01:43 (6y ago). Last successful fetch was on September 10, 2018 12:25 (6y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 158658753 series 57058
Content provided by GW Office for Clinical Practice Innovation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GW Office for Clinical Practice Innovation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr. David Diemert is an innovative research focused on developing an effective hookworm vaccine and characterizing hookworm biology. An Associate Professor of The Department of Microbiology, Immunology, and Tropical Medicine (MITM), Dr. Diemert co-hosts the clinical immunology laboratory and clinical trials unit of the Sabin Vaccine Institute Product Development Partnership (Sabin PDP), an Albert B. Sabin Vaccine Institute-funded partnership to develop new vaccines for neglected tropical diseases. In collaboration, both labs are currently running five phase 1 clinical trials for a hookworm vaccine: Two of these trials are carried out at the Children’s National Medical Center and the GW Medical Faculty Associates in Washington D.C., two in collaboration with the Oswaldo Cruz Foundation (FIOCRUZ) in Belo Horizonte and Americaninhas (Minas Gerais) in Brazil and one in Lambaréné in Gabon.

  continue reading

42 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide